How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency?
dc.rights.license | open | en_US |
hal.structure.identifier | Paris-Centre de Recherche Cardiovasculaire [PARCC (UMR_S 970/ U970)] | |
dc.contributor.author | MAUGE, Laetitia | |
dc.contributor.author | MADAR, Hugo | |
hal.structure.identifier | Ischémie reperfusion, métabolisme et inflammation stérile en transplantation [U 1313] [IRMETIST [Poitiers]] | |
dc.contributor.author | CARRÉ, Julie | |
hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
dc.contributor.author | FIORE, Mathieu | |
hal.structure.identifier | F-Crin INvestigation Network On Venous Thrombo-Embolism [CHU Saint-Etienne] [ Innovte] | |
hal.structure.identifier | Hôpital Européen Georges Pompidou [APHP] [HEGP] | |
hal.structure.identifier | Paris-Centre de Recherche Cardiovasculaire [PARCC (UMR_S 970/ U970)] | |
dc.contributor.author | GENDRON, Nicolas | |
dc.contributor.author | MOUTON, Christine | |
dc.contributor.author | PROULLE, Valérie | |
dc.contributor.author | SUCHON, Pierre | |
hal.structure.identifier | Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research [C2VN] | |
dc.contributor.author | TRILLOT, Nathalie | |
dc.contributor.author | LECHAT, Thomas | |
dc.contributor.author | SENTILHES, Loïc | |
hal.structure.identifier | Ischémie reperfusion, métabolisme et inflammation stérile en transplantation [U 1313] [IRMETIST [Poitiers]] | |
dc.contributor.author | MACCHI, Laurent | |
dc.date.accessioned | 2025-09-01T07:11:46Z | |
dc.date.available | 2025-09-01T07:11:46Z | |
dc.date.issued | 2025-07-08 | |
dc.identifier.issn | 0340-6245 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/207529 | |
dc.description.abstractEn | Inherited antithrombin deficiency (ATD) is associated with a high risk of venous thromboembolic complications. Association of ATD with other conditions such as pregnancy obviously increases thromboembolic risk and may require anticoagulant therapy for prevention. Although there are several/heterogenous international guidelines regarding thromboprophylaxis in pregnant patients with ATD, data on anticoagulant prophylaxis in this context are scarce in the literature. Thus, this situation remains a challenge both in the antepartum period and during delivery. Physicians from the French Society of Thrombosis and Haemostasis (SFTH) performed a review of the literature to suggest propositions regarding the management of thrombosis prevention based on anticoagulation and antithrombin substitution in ATD pregnant women. In this review, after reporting the thrombotic risk associated with ATD, the indication of anticoagulant therapy, its dosing regimen and monitoring, and the indication of antithrombin concentrates during pregnancy and the postpartum period are discussed as well as peripartum management. Finally, this work confirms the complex management of thrombotic prevention in pregnant patients with ATD. Indeed, it requires to take into account a multiplicity of features cited in our propositions that will hopefully provide some help in this field. This work also highlights the importance of multidisciplinary discussions for pregnant women with ATD who should be counseled in an expert center including hematologist, obstetrician, and anesthetist to optimize their management. | |
dc.language.iso | EN | en_US |
dc.subject.en | Pregnancy | |
dc.subject.en | antithrombin deficiency | |
dc.subject.en | venous thrombosis | |
dc.subject.en | Thromboprophylaxis | |
dc.title.en | How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency? | |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1055/a-2650-7959 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Médecine humaine et pathologie | en_US |
dc.identifier.pubmed | 40628415 | en_US |
bordeaux.journal | Thrombosis and Haemostasis | en_US |
bordeaux.hal.laboratories | Biologie des maladies cardiovasculaires (BMC) - UMR 1034 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.import.source | hal | |
hal.identifier | hal-05216850 | |
hal.version | 1 | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | false | |
workflow.import.source | hal | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Thrombosis%20and%20Haemostasis&rft.date=2025-07-08&rft.eissn=0340-6245&rft.issn=0340-6245&rft.au=MAUGE,%20Laetitia&MADAR,%20Hugo&CARR%C3%89,%20Julie&FIORE,%20Mathieu&GENDRON,%20Nicolas&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |